Comprador para empresa CDMO de API genéricos en Europa

Empresa para comprar

• Tamaño: Mediana empresa
• Revenue: 3 -30 million EUR
• Lugar de destino: Europa
• CFIE PHB262

Overview of buyer for generic API CDMO company in Europe

The company is a global, science-led pharmaceutical organization with over five decades of experience. In particular, in the pharmaceutical, chemical, and healthcare industries. Currently, it seeks to expand its presence through the acquisition of a generic API CDMO in Europe.

At this time, the organization has established itself as a significant player in the global pharmaceutical and healthcare arena. Over several decades, it has developed a strong reputation for its expertise in the development, scale-up, and commercialization of pharmaceutical products. Chiefly, the company’s focus is on becoming the integrated growth partner of choice for businesses worldwide.

Profile of buyer for generic API CDMO company in Europe

With a longstanding commitment to quality, integrity, leadership, respect, and sustainability, this organization has built extensive relationships with customers globally. Crucially, its capabilities in process chemistry, engineering, and manufacturing have enabled it to evolve as a strategic partner. Especially, involving collaboration, development, and manufacturing advanced pharmaceutical intermediates and APIs.

Activity and products of buyer for generic API CDMO company in Europe

Overall, the company is recognized as a key player in the production of artificial sweeteners, particularly saccharin, and contrast media intermediates. Further, it has also expanded its operations to include contract development and manufacturing, focusing on niche advanced intermediates and APIs. Essentially, the company applies cutting-edge processes to products at all phases. Thus, ensuring a robust and customized approach to meet customer needs.

Highlights of buyer for generic API CDMO company in Europe

• Experiencia: Over 50 years of industry expertise
• Alcance mundial: Operations in more than 50 countries, serving 140+ customers
• Manufacturing facilities: Four state-of-the-art facilities dedicated to innovation and quality
• Sustainability commitment: Aligned with the United Nations’ Sustainability Goals, the company is dedicated to green chemistry, pollution minimization, and carbon emission reduction

Altogether, this organization’s strategic growth plan includes new projects, products, and technologies, Moreover, it includes making strategic acquisitions and investments, particularly in the European market.

Más información Comprador para empresa CDMO de API genéricos en Europa

Póngase en contacto con nosotros si está interesado en saber más sobre Comprador para empresa CDMO de API genéricos en Europa. Para más empresas farmacéuticas en venta, visite la sección empresas farmacéuticas en venta.. Para otros compradores de productos farmacéuticos, visite la sección se buscan empresas farmacéuticas. Si por el contrario está interesado en empresas farmacéuticas en venta, visite la sección empresas farmacéuticas en venta. Para los compradores de productos farmacéuticos, visite la sección se buscan empresas farmacéuticas.